Selected publications
- Ansorena E., De Berdt P., Ucakar B., Simon-Yarza T., Jacobs D., Schakman O., Jankovski A., Deumens R., Blanco-Prieto M.J., Préat V., des Rieux A.
Injectable alginate hydrogel loaded with GDNF promotes functional recovery in a hemisection model of spinal cord injury.
Int J Pharm (2013), 455: 148-58. - De Berdt P., Vanacker J., Ucakar B., Elens L., Diogenes A., Leprince J.G., Deumens R., des Rieux A.
Dental Apical Papilla as Therapy for Spinal Cord Injury.
J Dent Res. (2015), 94(11):1575-1581. - des Rieux A., Fievez V., Theate I., Mast J., Préat V., Schneider Y.J.
An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells.
Eur J Pharm Sci (2007), 30: 380-91. - des Rieux A., Fievez V., Garinot M., Schneider Y.J., Préat V.
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
J Control Release (2006), 116: 1-27. - Lambricht L., De Berdt P., Vanacker J., Leprince J., Diogenes A., Goldansaz H., Bouzin C., Préat V., Dupont-Gillain C., des Rieux A.
The type and composition of alginate and hyaluronic-based hydrogels influence the viability of stem cells of the apical papilla.
Dent Mater (2014), 30:e349-361.
- Vanacker J., Viswanath A., De Berdt P., Everard A., Cani P. D., Bouzin C., Feron, O., Diogenes A., Leprince J. G., des Rieux A.
Hypoxia Modulates the Differentiation Potential of Stem Cells of the Apical Papilla.
J. Endodontics (2014), 40: 1410-1418. - Randolph L. D., Palin W. M., Bebelman S., Devaux J., Gallez B., Leloup G., Leprince, J. G.
Ultra-fast light-curing resin composite with increased conversion and reduced monomer elution.
Dent Mater (2014), 30: 594-604. - Setbon H.M., Devaux J., Iserentant A., Leloup G., Leprince J.G.
Influence of composition on setting kinetics of new injectable and/or fast setting tricalcium silicate cements. Dent Mater (2014), 30:1291-303. - Leprince J. G., Palin W. M., Hadis M. A., Devaux J., Leloup G.
Progress in dimethacrylate-based dental composite technology and curing efficiency.
Dent Mater (2013), 29: 139-156. - Leprince J. G., Leveque P., Nysten B., Gallez B., Devaux J., Leloup G.
New insight into the “depth of cure” of dimethacrylate-based dental composites.
Dent Mater (2012), 28: 512-520.
- Danhier F., Feron O., Préat V.
To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
J Control Release (2010), 148: 135-146. - Danhier F., Vroman B., Lecouturier N., Crokart N., Pourcelle V., Freichels H., Jérôme C, Marchand-Brynaert J., Feron O., Préat V.
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel.
J Control Release (2009), 140: 166-173. - Garinot M., Fievez V., Pourcelle V., Stoffelbach F., des Rieux A., Plapied L., Theate I., Freichels H., Jerôme C., Marchand Brynaert J., Schneider Y.J., Préat V.
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination.
J Control Release (2007), 120: 195-204. - des Rieux A., Fievez V., Garinot M., Schneider Y.J., Préat V.
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
J Control Release (2006), 116: 1-27. - Denet A.R., Vanbever R., Préat V.
Skin electroporation for transdermal and topical delivery. Advanced Drug Delivery Reviews (2004), 56: 659-674.
- Koussoroplis S.J., Paulissen G., Tyteca D., Goldansaz H., Todoroff J., Barilly C., Uyttenhove C., Van Snick J., Cataldo D., Vanbever R. PEGylation of antibody fragments greatly increases their local residence time following delivery to the respiratory tract.
J. Control Release (2014), 187: 91-100. - Loira-Pastorisa C., Todoroff J., Vanbever R.
Delivery strategies for sustained drug release in the lungs (invited review).
Adv. Drug Deliv. Rev. (2014), 75: 81-91. - Todoroff J., Vanbever R.
Fate of nanomedicines in the lungs (invited review).
Curr. Opin. Coll. Interf. Sc (2011), 16: 246-254. - Minne A., Louahed J., Mehauden S., Baras B., Renauld J.-C., Vanbever R.
The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response.
Immunology (2007), 122: 316-325. - Lombry C., Edwards D.A., Préat V.,Vanbever R.
Alveolar macrophages are a primary barrier to pulmonary absorption of macromolecules.
Am. J. Physiol. Lung Cell Mol. Physiol. (2004), 286: L1002-L1008.